An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions

The antiphospholipid antibody syndrome is a systemic, acquired, immune-mediated disorder characterized by episodes of venous, arterial, or microcirculation thrombosis and/or pregnancy abnormalities, associated with the persistent presence of autoantibodies, confirmed at least in two occasions 12 weeks apart, directed to molecular complexes consisting of phospholipids and proteins. Antiphospholipid antibody syndrome should always be considered as a potential diagnosis especially for young patients presenting with a history of thrombotic events, in particular when they occur without any obvious external trigger or any inherited thrombophilic mutation (even if 2006 criteria do not exclude antiphospholipid antibody syndrome in patients with other inherited or acquired prothrombotic conditions), or for women with recurrent pregnancy losses or later fetal deaths. Many other disorders are able to mimic antiphospholipid antibody syndrome, so a broad range of alternative diagnoses should be investigated and ruled out during clinical workup.

[1]  Yulia Einav,et al.  Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. , 2014, Autoimmunity reviews.

[2]  E. Silvestri,et al.  Anti-TNF-α agents in vascular Behçet's disease , 2014, Expert review of cardiovascular therapy.

[3]  R. Cervera,et al.  Renal Involvement in Antiphospholipid Syndrome , 2014, Current Rheumatology Reports.

[4]  N. Hill,et al.  Primary antiphospholipid syndrome and pulmonary hypertension. , 2014, Current pharmaceutical design.

[5]  D. Boumpas,et al.  Pathogenesis and treatment of CNS lupus , 2013, Current opinion in rheumatology.

[6]  M. Khamashta,et al.  Seronegative antiphospholipid syndrome. , 2013, Rheumatology.

[7]  J. Alijotas-Reig,et al.  Current Concepts and New Trends in the Diagnosis and Management of Recurrent Miscarriage , 2013, Obstetrical & gynecological survey.

[8]  G. Vaiopoulos,et al.  The lung in the spectrum of antiphospholipid syndrome. , 2013, Clinical and experimental rheumatology.

[9]  K. Heimdal,et al.  Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[10]  O. Sedrati,et al.  Le syndrome de Sneddon , 2013 .

[11]  G. Remuzzi,et al.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation , 2012, Nature Reviews Nephrology.

[12]  I. Martinelli,et al.  Cerebral sinus-venous thrombosis , 2012, Internal and Emergency Medicine.

[13]  M. D’Elios,et al.  Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle. , 2012, Clinical and experimental rheumatology.

[14]  M. Papadopoulos,et al.  Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.

[15]  D. Gillis,et al.  Rarer Clinical Associations of Antiphospholipid Antibodies , 2012, Seminars in Thrombosis & Hemostasis.

[16]  R. Podemski,et al.  Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis , 2012, Lupus.

[17]  Y. Shoenfeld,et al.  HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. , 2011, Seminars in arthritis and rheumatism.

[18]  P. D. de Groot,et al.  Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment , 2011, Journal of internal medicine.

[19]  G. Zlatanović,et al.  Anticardiolipin antibodies in patients with Behcet's disease. , 2011, Bosnian journal of basic medical sciences.

[20]  S. Dean.  Livedo Reticularis and Related Disorders , 2011, Current treatment options in cardiovascular medicine.

[21]  I. Uthman,et al.  Antiphospholipid Syndrome: Endocrinologic Manifestations and Organ Involvement , 2011, Seminars in thrombosis and hemostasis.

[22]  C. Francès.  Dermatological manifestations of Hughes’ antiphospholipid antibody syndrome , 2010, Lupus.

[23]  S. Colagrande,et al.  Devic’s syndrome and primary APS: a new immunological overlap , 2010, Lupus.

[24]  Drew Provan,et al.  International consensus report on the investigation and management of primary immune thrombocytopenia. , 2010, Blood.

[25]  M. Tektonidou.  Renal Involvement in the Antiphospholipid Syndrome (APS)—APS Nephropathy , 2009, Clinical reviews in allergy & immunology.

[26]  Y. Shoenfeld,et al.  Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". , 2009, Journal of autoimmunity.

[27]  V. Valtchev,et al.  SNEDDON'S SYNDROME , 2009 .

[28]  R. Mantilla,et al.  Osteonecrosis and antiphospholipid syndrome. , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[29]  D. Kidd,et al.  Neuro-Behçet's disease: epidemiology, clinical characteristics, and management , 2009, The Lancet Neurology.

[30]  B. Chong,et al.  Heparin-induced thrombocytopenia: What clinicians need to know , 2009, Thrombosis and Haemostasis.

[31]  H. Glimm,et al.  Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up , 2008, Lupus.

[32]  J. Walenga,et al.  The Laboratory Diagnosis and Clinical Management of Patients with Heparin-Induced Thrombocytopenia: An Update , 2008, Seminars in thrombosis and hemostasis.

[33]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[34]  C. D. di Gioia,et al.  Dilated Cardiomyopathy Due to Thrombotic Microangiopathy as the only Manifestation of Antiphospholipid Syndrome: A Case Report , 2008, International journal of immunopathology and pharmacology.

[35]  M. Khamashta,et al.  The abdominal manifestations of the antiphospholipid syndrome. , 2007, Rheumatology.

[36]  L. Stojanovich,et al.  Ocular manifestations in antiphospholipid syndrome. , 2007, Autoimmunity reviews.

[37]  H. Link,et al.  Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness , 2006, Journal of Neuroimmunology.

[38]  D. D'cruz,et al.  Cerebral manifestations in the antiphospholipid (Hughes) syndrome. , 2006, Rheumatic diseases clinics of North America.

[39]  Y. Shoenfeld,et al.  Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? , 2006, The Journal of rheumatology.

[40]  N. Herial,et al.  Sneddon's Syndrome , 2006, Cephalalgia : an international journal of headache.

[41]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[42]  J. Stam.  Thrombosis of the cerebral veins and sinuses. , 2005, The New England journal of medicine.

[43]  H. Moutsopoulos,et al.  Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. , 2004, Arthritis and rheumatism.

[44]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[45]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[46]  J. Merrill,et al.  Catastrophic antiphospholipid syndrome , 2006, Nature Clinical Practice Rheumatology.

[47]  M. Khamashta,et al.  Can Neurologic Manifestations of Hughes (Antiphospholipid) Syndrome Be Distinguished from Multiple Sclerosis?: Analysis of 27 Patients and Review of the Literature , 2000, Medicine.

[48]  P. Lazzarin,et al.  Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. , 1990, Annals of the rheumatic diseases.

[49]  S. Cutillo.  [Hemolytic-uremic syndrome]. , 1973, La Pediatria.

[50]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.

[51]  M. Wislowska.  [Catastrophic antiphospholipid syndrome]. , 2015, Wiadomosci lekarskie.

[52]  G. Geri,et al.  [Cardiac involvement in antiphospholipid syndrome]. , 2011, Presse medicale.

[53]  R. Cervera,et al.  Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? , 2008, Autoimmunity reviews.

[54]  J. Piette,et al.  The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. , 2006, Clinical and experimental rheumatology.

[55]  J. Stam.  current concepts Thrombosis of the Cerebral Veins and Sinuses , 2005 .